Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-111260
Filing Date
2025-11-13
Accepted
2025-11-13 16:02:01
Documents
63
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20250930x10q.htm   iXBRL 10-Q 1630956
2 EX-31.1 fencf-20250930xex31d1.htm EX-31.1 13858
3 EX-31.2 fencf-20250930xex31d2.htm EX-31.2 18440
4 EX-32.1 fencf-20250930xex32d1.htm EX-32.1 9272
5 EX-99.1 fencf-20250930xex99d1.htm EX-99.1 204507
6 GRAPHIC fencf-20250930xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001104659-25-111260.txt   7369290

Data Files

Seq Description Document Type Size
7 EX-101.SCH fencf-20250930.xsd EX-101.SCH 49998
8 EX-101.CAL fencf-20250930_cal.xml EX-101.CAL 38958
9 EX-101.DEF fencf-20250930_def.xml EX-101.DEF 198933
10 EX-101.LAB fencf-20250930_lab.xml EX-101.LAB 354595
11 EX-101.PRE fencf-20250930_pre.xml EX-101.PRE 315025
66 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20250930x10q_htm.xml XML 1303489
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 251478190
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)